Carol J. Weil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carol J. Weil has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Carolyn Compton
Office of Biorepositories and Biospecimen Research, Center for Strategic Scientific Initiatives, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publicationChristopher Kinsinger
Office of Cancer Clinical Proteomics Research, Center for Strategic and Scientific Initiatives, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publicationLaura D. Buccini
Division of Cancer Control and Population Sciences, Host Susceptibility Factors Branch, Epidemiology and Genomics Research Program, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publicationLaura L. Rodriguez
Division of Policy, Communications and Education, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
1 shared publicationLeah E. Mechanic
Division of Cancer Control and Population Sciences, Host Susceptibility Factors Branch, Epidemiology and Genomics Research Program, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publicationNicole C. Lockhart
Division of Genomics and Society, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2013
- Published by Elsevier in Genetics in Medicine
- Vol. 15 (12) , 997-1003
NCI think tank concerning the identifiability of biospecimens and “omic” data
- 1 December 2013
- Published by Elsevier in Genetics in Medicine
- Vol. 15 (12) , 997-1003
Open AccessNCI think tank concerning the identifiability of biospecimens and “omic” data
- Open Access
- 1 February 2012
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 21 (2) , 256-259
Sharing Individual Research Results with Biospecimen Contributors: Point
Biospecimens are an essential resource for biomedical research, including research that aims to decipher the biology of cancer and improve its clinical management. Accordingly, patients with cancer and others who contribute biospecimens for research are increasingly attentive to the results of
- 1 February 2012
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 21 (2) , 256-259
Open AccessSharing Individual Research Results with Biospecimen Contributors: Point
Biospecimens are an essential resource for biomedical research, including research that aims to decipher the biology of cancer and improve its clinical management. Accordingly, patients with cancer and others who contribute biospecimens for research are increasingly attentive to the results of
- 16 September 2011
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 333 (6049) , 1574-1575
Trade-Secret Model: Potential Pitfalls
In their Policy Forum “Genomics, Biobanks, and the trade-secret model” (15 April, p. [309][1]), R. Mitchell et al. submit that donating genetic samples for medical research is like selling a confidential commodity of potentially lucrative value, warranting individual licensing arrangements to
- 16 September 2011
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 333 (6049) , 1574-1575
Trade-Secret Model: Potential Pitfalls
In their Policy Forum “Genomics, Biobanks, and the trade-secret model” (15 April, p. [309][1]), R. Mitchell et al. submit that donating genetic samples for medical research is like selling a confidential commodity of potentially lucrative value, warranting individual licensing arrangements to